Recently Viewed
Clear AllValue Research Rating
Quality Score 
0/0
Growth Score
0/0
Valuation Score
0/0
Momentum Score
0/0
Today’s Range
52 Week Range
Liquidity
Market cap
₹263 Cr
Revenue (TTM)
₹147 Cr
Net Profit (TTM)
₹10 Cr
ROE
5 %
ROCE
6.3 %
P/E Ratio
27.2
P/B Ratio
2.8
Industry P/E
26.59
EV/EBITDA
15.1
Div. Yield
0 %
Debt to Equity
0.3
Book Value
₹39.3
EPS
₹4.8
Face value
10
Shares outstanding
23,656,335
CFO
₹-10.49 Cr
EBITDA
₹7.63 Cr
Net Profit
₹-38.87 Cr
|
Company
|
YTD
|
1 Month
|
3 Months
|
1 Year
|
3 Years
|
5 Years
|
10 Years
|
|---|---|---|---|---|---|---|---|
|
Bafna Pharma
| -26.1 | 4.9 | -25.0 | 48.8 | 10.7 | -3.1 | -9.5 |
|
BSE Healthcare
| -4.7 | -5.8 | -5.4 | 1.3 | 23.7 | 14.0 | 10.6 |
|
Company
|
2025
|
2024
|
2023
|
2022
|
2021
|
|---|---|---|---|---|---|
|
Bafna Pharma
| 82.1 | -15.2 | -8.7 | -34.0 | -9.9 |
|
BSE Small Cap
| -6.6 | 29.0 | 47.5 | -1.8 | 62.8 |
|
BSE Healthcare
| -3.3 | 43.1 | 37.0 | -12.1 | 20.9 |
Is there a threat to the company's solvency?
Can creative accounting be detected through the financial numbers?
How did the company perform in the last one year?
5Y Avg -- 3Y Avg -- TTM --
P/E Ratio
--
--Min --Median --Max
P/B Ratio
--
--Min --Median --Max
Earnings Yield (%)
--
Earnings Yield (%) = EBIT / Enterprise value
PEG Ratio
--
Price = Price / Earnings to growth ratio
Company |
Price (₹) | Market Cap (₹ Cr) | Revenue (TTM) | Net Profit (TTM) | OPM (%) | ROE (%) | P/E | P/B |
|---|---|---|---|---|---|---|---|---|
|
Bafna Pharma
|
111.3 | 262.6 | 147.4 | 9.7 | 7.4 | 13 | 27.2 | 2.8 |
| 2,791.2 | 34,920.1 | 5,201.6 | 1,014.6 | 22.9 | 25 | 34.4 | 7.6 | |
| 7,827.5 | 19,544.3 | 2,177.5 | 200.9 | 11.3 | 26.5 | 97.3 | 23.5 | |
| 1,565.8 | 11,917.5 | 2,089.5 | 622.0 | 31.3 | 20.4 | 19.4 | 3.6 | |
| 1,499.2 | 9,167.3 | 1,196.4 | 149.4 | -- | 27.5 | 61.3 | 13.1 | |
| 1,332.1 | 18,429.0 | 3,078.2 | 469.4 | 26.4 | 14.9 | 42.7 | 5.1 | |
| 1,961.1 | 31,410.1 | 4,193.0 | 753.8 | 22.7 | 20.8 | 41.7 | 7.8 | |
| 4,887.1 | 22,333.8 | 2,482.3 | 853.6 | 33.7 | 18.9 | 26.2 | 5.6 | |
| 4,778.6 | 7,918.9 | 1,348.5 | 293.5 | 28.1 | 50.7 | 27 | 11.4 | |
| 971.2 | 8,938.5 | 4,725.6 | 528.7 | 14.9 | 20.7 | 17.5 | 3.0 |
No Review & Analysis are available.
Bafna Pharmaceuticals Limited manufactures and sells finished pharmaceutical formulations in India. It also exports its products to Europe, the United Kingdom, Australia, Sri Lanka, Africa, Philippines, Tanzania, Nigeria, and Commonwealth countries.... Bafna Pharmaceuticals Limited was founded in 1981 and is based in Chennai, India. Bafna Pharmaceuticals Limited is a subsidiary of SRJR Lifesciences LLP. Read more
Incorporated
1995
Chairman
--
Managing Director
--
Headquarters
Chennai, Tamil Nadu
Website
Looking for more details about Bafna Pharmaceuticals Ltd.’s IPO? Explore our IPO Details page.
Our rating system has guided millions of investors in the past 20 years.
Annual Reports
The share price of Bafna Pharmaceuticals Ltd is ₹111.32 (NSE) and ₹111.00 (BSE) as of 02-Apr-2026 IST. Bafna Pharmaceuticals Ltd has given a return of 10.73% in the last 3 years.
The P/E ratio of Bafna Pharmaceuticals Ltd is 27.17 times as on 02-Apr-2026, a 2 premium to its peers’ median range of 26.59 times.
The P/B ratio of Bafna Pharmaceuticals Ltd is 2.82 times as on 02-Apr-2026, a 37 discount to its peers’ median range of 4.49 times.
PE & PB ratio at the end of financial year.
| Year | P/E Ratio | P/B Ratio |
|---|---|---|
|
2025
|
42.73
|
2.09
|
|
2024
|
24.68
|
2.24
|
|
2023
|
17.24
|
2.66
|
|
2022
|
57.59
|
4.85
|
|
2021
|
55.74
|
5.72
|
The 52-week high and low of Bafna Pharmaceuticals Ltd are Rs 202.06 and Rs 70.61 as of 04-Apr-2026.
Bafna Pharmaceuticals Ltd has a market capitalisation of ₹ 263 Cr as on 02-Apr-2026. As per SEBI classification, it is a Small Cap company.
Before investing in Bafna Pharmaceuticals Ltd, assess your goals, risk tolerance, and if the company aligns with your long-term plan. Carefully review its business model, financials, and valuation. Avoid making decisions based on tips or short-term trends.
₹-0.64
(
New Process Alert 
Seems like you've uploaded a wrong QR code. Please upload the QR code downloaded from MF Central platform.